Nick Laursen


Commit Biologics ApS


Commit Biologics has developed a novel platform technology to harness the power of the complement system, a vital part of the innate immune system. With a unique mechanism of action, the technology has the potential to create a new type of immunotherapy for the treatment of a variety of cancers.

© All rights reserved, Sciencenews 2020